Related Experiment Video
Updated: Sep 28, 2025

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
[Intestinal microbe Prevotella in pulmonary tuberculosis research]
Abstract:
Tuberculosis is a major global infectious disease that seriously endangers human health. Studies have shown that there will be an imbalance of intestinal microecology after infection with Mycobacterium tuberculosis. And vise versa the imbalance of intestinal flora will also increase the susceptibility to Mycobacterium tuberculosis. Prevotella is a newly discovered intestinal microorganism closely related to inflammatory diseases, and its abundance changes significantly in patients with tuberculosis. Therefore, this paper reviews the correlation between intestinal microorganism Prevotella and pulmonary tuberculosis, in order to provide new ideas for the diagnosis and treatment of pulmonary tuberculosis.
Insights
Tuberculosis infection disrupts gut bacteria, potentially increasing susceptibility. Prevotella, an intestinal microbe linked to inflammation, shows altered levels in tuberculosis patients, suggesting a diagnostic and therapeutic link.
Area of Science:
- Microbiology
- Infectious Diseases
- Human Health
Background:
- Tuberculosis (TB) is a significant global health threat.
- Mycobacterium tuberculosis infection causes intestinal microecological imbalance.
- Intestinal flora imbalance can increase susceptibility to M. tuberculosis.
Purpose of the Study:
- To review the relationship between Prevotella and pulmonary tuberculosis.
- To explore novel diagnostic and therapeutic strategies for TB.
Main Methods:
- Literature review on Prevotella and tuberculosis.
- Analysis of studies investigating gut microbiota in TB patients.
Main Results:
- Prevotella abundance is significantly altered in tuberculosis patients.
- Prevotella is associated with inflammatory responses relevant to TB.
Conclusions:
- Prevotella may serve as a biomarker for tuberculosis.
- Targeting Prevotella could offer new avenues for TB treatment.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...

